The CareVoice has successfully raised an eight-figure USD Series A funding round, led by LUN Partners Group, to enhance its innovative health insurtech solutions and expand its market presence in Asia.
Target Company Overview
The CareVoice is an international health insurtech company headquartered in China, specializing in digital healthcare solutions for insurance providers. Recently, the company successfully secured an eight-figure USD Series A funding round, led by the global investment firm LUN Partners Group, alongside notable participants such as DNA Capital, SOSV, and Artesian Capital. The CareVoice has developed a data-driven Software as a Service (SaaS) solution that enhances the healthcare and insurance experience for consumers, already adopted by 15 local and international insurers including notable names like Ping An and AXA.
In addition to its core offerings, The CareVoice has launched CareVoiceOSTM, the first dedicated healthcare “Operating System” for insurers. This innovative platform equips insurance companies with an end-to-end technology solution designed to create customized and efficient insurance plans while connecting them with a network of healthcare services.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in China
China's private health insurance sector is experiencing significant growth, responding to an increasing consumer demand for improved digital solutions in healthcare management. This surge in demand comes at a time when traditional insurance p
Similar Deals
Apricot Capital → Vibrant Therapeutics (Guangzhou) Co., Ltd.
2025
LUN Partners Group
invested in
The CareVoice
in 2023
in a Series A deal